This brand name is authorized in Austria, Cyprus, Estonia, Israel
The drug MYOCHOLINE contains one active pharmaceutical ingredient (API):
|
1
Bethanechol
UNII H4QBZ2LO84 - BETHANECHOL CHLORIDE
|
|
Bethanechol chloride, a cholinergic agent, is a synthetic ester which is structurally and pharmacologically related to acetylcholine. Bethanechol chloride acts principally by producing the effects of stimulation of the parasympathetic nervous system. It stimulates gastric motility, increases gastric tone and often restores impaired rhythmic peristalsis. It is not destroyed by cholinesterase and its effects are more prolonged than those of acetylcholine. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N07AB02 | Bethanechol | N Nervous system → N07 Other nervous system drugs → N07A Parasympathomimetics → N07AB Choline esters |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1858675 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9421 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
